EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Oestrogen receptor positive breast cancer and its embedded mechanism: breast cancer resistance to conventional drugs and related therapies, a review

Manu Yadav, Ishita Vaishkiar, Ananya Sharma, Akanksha Shukla, Aradhana Mohan, Madhuri Girdhar, Anil Kumar iD, Tabarak Malik iD, Anand Mohan iD

Open Biology · 2024-06 · 14 (6)

DOI: 10.1098/rsob.230272 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Open Biology, online erschienen am 19.06.2024. Verfasst von Manu Yadav und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetics, ICAR- Indian Agricultural Research Institute , Pusa, New Delhi, India. Hauptthemen laut MEDLINE: Breast Neoplasms, Drug Resistance, Neoplasm, Epigenesis, Genetic. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traditional medication and alternative therapies have long been used to treat breast cancer. One of the main problems with current treatments is that there is an increase in drug resistance in the cancer cells owing to genetic differences such as mutational changes, epigenetic changes and miRNA (microRNA) alterations such as miR-1246, miR-298, miR-27b and miR-33a, along with epigenetic modifications, such as Histone3 acetylation and CCCTC-Binding Factor (CTCF) hypermethylation for drug resistance in breast cancer cell lines. Certain forms of conventional drug resistance have been linked to genetic changes in genes such as ABCB1 , AKT , S100A8/A9 , TAGLN2 and NPM . This review aims to explore the current approaches to counter breast cancer, the action mechanism, along with novel therapeutic methods endowing potential drug resistance. The investigation of novel therapeutic approaches sheds light on the phenomenon of drug resistance including genetic variations that impact distinct forms of oestrogen receptor (ER) cancer, genetic changes, epigenetics-reported resistance and their identification in patients. Long-term effective therapy for breast cancer includes selective oestrogen receptor modulators, selective oestrogen receptor degraders and genetic variations, such as mutations in nuclear genes, epigenetic modifications and miRNA alterations in target proteins. Novel research addressing combinational therapies including maytansine, photodynamic therapy, guajadiol, talazoparib, COX2 inhibitors and miRNA 1246 inhibitors have been developed to improve patient survival rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsDrug Resistance, NeoplasmEpigenesis, GeneticHumansFemaleReceptors, EstrogenGene Expression Regulation, NeoplasticMicroRNAsAntineoplastic Agents

Stichwörter der Autor:innen

breast cancerdrug-resistanceepigenetic alterationsmiRNA alterationnovel targettherapeutic approaches

Substanzen

Receptors, EstrogenMicroRNAsAntineoplastic Agents

Autor:innen und Institutionen

  • Division of Genetics, ICAR- Indian Agricultural Research Institute , Pusa, New Delhi, India.
  • Amity Institute of Biotechnology (AIB) University, Amity University Noida , Noida, India.
  • Department: Botany and Microbiology, Hemwati Nandan Bahuguna Garhwal University , Srinagar, India.
  • School of Bioengineering and Biosciences, Lovely Professional University , Phagwara, Punjab, India.
  • Department of Biomedical Engineering, University of Michigan , Ann Arbor, MI, USA.
  • Division of Research and Development, Lovely Professional University , Phagwara, Punjab, India.

ORCID-Profile: Anil Kumar, Tabarak Malik, Anand Mohan

Zitieren

APA

Yadav, M., Vaishkiar, I., Sharma, A., Shukla, A., Mohan, A., Girdhar, M., Kumar, A., Malik, T., & Mohan, A. (2024). Oestrogen receptor positive breast cancer and its embedded mechanism: breast cancer resistance to conventional drugs and related therapies, a review. Open Biology, 14(6). https://doi.org/10.1098/rsob.230272

Vancouver

Yadav M, Vaishkiar I, Sharma A, Shukla A, Mohan A, Girdhar M, et al. Oestrogen receptor positive breast cancer and its embedded mechanism: breast cancer resistance to conventional drugs and related therapies, a review. Open Biology. 2024;14(6). doi:10.1098/rsob.230272

BibTeX
@article{Yadav2024,
  author = {Yadav, Manu and Vaishkiar, Ishita and Sharma, Ananya and Shukla, Akanksha and Mohan, Aradhana and Girdhar, Madhuri and Kumar, Anil and Malik, Tabarak and Mohan, Anand},
  title = {Oestrogen receptor positive breast cancer and its embedded mechanism: breast cancer resistance to conventional drugs and related therapies, a review},
  journal = {Open Biology},
  year = {2024},
  volume = {14},
  number = {6},
  doi = {10.1098/rsob.230272}
}
Kostenlos starten →